Biocon Partners with a Canadian Company to Develop a Diabetic Medication
Biocon Ltd announced on 6 October that it has inked a deal with Juno Pharmaceuticals, a Canadian specialized corporation, for the commercialization of Liraglutide, a drug-device combination for the treatment
